News
New rules are reshaping the telehealth market for GLP-1s like Ozempic and Wegovy, potentially impacting access to these drugs for millions of people.
As a mass rollout of weight loss injections begins across the NHS, with GPs able to prescribe Mounjaro for the first time ...
The Delhi High Court on Tuesday disposed of a public interest litigation (PIL) raising alarm over the off-label and ...
15d
Zacks Investment Research on MSNCan Ozempic, Wegovy Drive Further Growth for NVO in the Obesity Space?Novo Nordisk NVO generates most of its revenues from the sales of its blockbuster GLP-1 injections, Ozempic for type II ...
The pharmaceutical company alleges Hims is widely selling cheaper versions of its blockbuster drugs, despite the FDA's recent ...
Novo Nordisk NVO generates most of its revenues from the sales of its blockbuster GLP-1 injections, Ozempic for type II diabetes (T2D) and Wegovy for obesity. Ozempic and Wegovy include the same ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results